UN puts AI Titans on the hook for billions of dollars of biopiracy payments
By Jim Thomas,
Scan the Horizon
| 11. 19. 2024
It’s the wee hours of 2nd November 2024 in Cali, Colombia. In a large UN negotiating hall Colombian Environment Minister Susana Muhamed has slammed down the gavel on a decision that should send a jolt through the AI policy world. The decision, while seemingly about paying for genetic data, sets a significant wider precedent for how AI firms can be held accountable for stealing training data without consent or recompense.
Here is the context: After years of stand-offs and diplomatic wrangling, the United Nation’s Convention on Biological Diversity (UN CBD) this month adopted a landmark decision on something called “DSI”. DSI stands for Digital Sequence Information. It refers to digital versions of biological ‘codes’ such as DNA, RNA or the amino acids in proteins. These biological “codes” are routinely collected, stored and processed in digital form and have become the raw commodity powering the global$1.5 trillion dollar biotech industry. Originally sequenced from plants, animals, bacteria and viruses extracted from territories (plus human medical samples) the sheer volume of ‘DSI’ now stacking up in servers and databases rivals much of...
Related Articles
Flag of South Africa; design by Frederick Brownell,
image by WikimediaCommons users.
Public domain, via Wikimedia Commons
What is the legal status of heritable human genome editing (HHGE)? In 2020, a comprehensive policy analysis by Baylis, Darnovsky, Hasson, and Krahn documented that more than 70 countries and an international treaty prohibit it, and that no country explicitly permits it. Policies in some countries were non-existent, ambiguous, or subject to possible amendment, but the general rule remained, even after one...
By Bernice Lottering, Gene Online | 11.08.2024
South Africa’s updated health-research ethics guidelines, which now include heritable human genome editing, have sparked concern among scientists. The revisions, made in May but only recently gaining attention, outline protocols for modifying genetic material in sperm, eggs, or embryos—changes that...
By Ned Pagliarulo, BioPharmaDive | 11.05.2024
A medicine built around a more precise form of CRISPR gene editing appeared to work as designed in its first clinical trial test, developer Beam Therapeutics said Tuesday. But the death of a trial participant could renew concerns about an older...
By Ruth Retassie, PET | 10.21.2024